Horizons Hegira Health

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient

Pharmacotherapies

Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Thioridazine Trifluoperazine Aripiprazole Brexpiprazole Cariprazine Clozapine Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Group therapy Individual psychotherapy Telemedicine/telehealth therapy

Facility Operation (e.g., Private, Public)

Private non-profit organization

Payment/Insurance/Funding Accepted

Community Mental Health Block Grants Medicaid

Payment Assistance Available

Sliding fee scale (fee is based on income and other factors)

Special Programs/Groups Offered

Clients with co-occurring mental and substance use disorders Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment

Screening for tobacco use

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy

Smoking permitted in designated area

Age Groups Accepted

Young Adults Seniors

Facility Vaping Policy

Vaping permitted in designated area

Ancillary Services

Assertive community treatment Court-ordered outpatient treatment Suicide prevention services